Cite
HARVARD Citation
Penas-Prado, M. et al. (2021). CTIM-32. IMMUNE CHECKPOINT INHIBITOR NIVOLUMAB IN PEOPLE WITH RECURRENT SELECT RARE CNS CANCERS: RESULTS OF INTERIM ANALYSIS IN A HEAVILY PRETREATED COHORT. Neuro-oncology. pp. vi57-vi58. [Online].